223 related articles for article (PubMed ID: 25417052)
61. A population study using the human erythrocyte PIG-A assay.
Cao Y; Yang L; Feng N; Shi O; Xi J; You X; Yin C; Yang H; Horibata K; Honma M; Qian B; Weng W; Luan Y
Environ Mol Mutagen; 2016 Oct; 57(8):605-614. PubMed ID: 27581231
[TBL] [Abstract][Full Text] [Related]
62. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT.
Kvarnung M; Nilsson D; Lindstrand A; Korenke GC; Chiang SC; Blennow E; Bergmann M; Stödberg T; Mäkitie O; Anderlid BM; Bryceson YT; Nordenskjöld M; Nordgren A
J Med Genet; 2013 Aug; 50(8):521-8. PubMed ID: 23636107
[TBL] [Abstract][Full Text] [Related]
63. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice.
Cao X; Mittelstaedt RA; Pearce MG; Allen BC; Soeteman-Hernández LG; Johnson GE; Bigger CA; Heflich RH
Environ Mol Mutagen; 2014 Jun; 55(5):385-99. PubMed ID: 24535894
[TBL] [Abstract][Full Text] [Related]
64. A combination of in vitro comet assay and micronucleus test using human lymphoblastoid TK6 cells.
Kimura A; Miyata A; Honma M
Mutagenesis; 2013 Sep; 28(5):583-90. PubMed ID: 23863314
[TBL] [Abstract][Full Text] [Related]
65. Molecular basis of paroxysmal nocturnal hemoglobinuria.
Parker CJ
Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of the Pig-a, micronucleus, and comet assay endpoints in a 28-day study with ethyl methanesulfonate.
Gunther WC; Coffing SL; Dickinson DA; Engel ME; Fiedler RD; O'Lone SD; Sanok KE; Thiffeault CJ; Shutsky TJ; Schuler MJ; Dobo KL
Environ Mol Mutagen; 2014 Jul; 55(6):492-9. PubMed ID: 24599777
[TBL] [Abstract][Full Text] [Related]
67. Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.
Hu R; Mukhina GL; Lee SH; Jones RJ; Englund PT; Brown P; Sharkis SJ; Buckley JT; Brodsky RA
Exp Hematol; 2009 Apr; 37(4):423-434.e2. PubMed ID: 19302917
[TBL] [Abstract][Full Text] [Related]
68. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.
Szpurka H; Schade AE; Jankowska AM; Maciejewski JP
Br J Haematol; 2008 Jul; 142(3):413-22. PubMed ID: 18544084
[TBL] [Abstract][Full Text] [Related]
69. Development of an in vitro PIG-A gene mutation assay in human cells.
Rees BJ; Tate M; Lynch AM; Thornton CA; Jenkins GJ; Walmsley RM; Johnson GE
Mutagenesis; 2017 Mar; 32(2):283-297. PubMed ID: 28057708
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of mutagenicity of acrylamide using RBC Pig-a and PIGRET assays by single peroral dose in rats.
Horibata K; Ukai A; Honma M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 811():54-59. PubMed ID: 27931815
[TBL] [Abstract][Full Text] [Related]
71. Detection of In Vivo Mutation in the Pig-a Gene of Mouse Bone Marrow Erythroids.
Kimoto T; Miura D
Methods Mol Biol; 2017; 1641():161-172. PubMed ID: 28748463
[TBL] [Abstract][Full Text] [Related]
72. Pig-a gene mutation and micronucleated reticulocyte induction in rats exposed to tumorigenic doses of the leukemogenic agents chlorambucil, thiotepa, melphalan, and 1,3-propane sultone.
Dertinger SD; Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Cottom J; Bemis JC; Macgregor JT
Environ Mol Mutagen; 2014 May; 55(4):299-308. PubMed ID: 24449360
[TBL] [Abstract][Full Text] [Related]
73. Application of the in vivo Pig-a gene mutation assay to test the potential genotoxicity of p-phenylenediamine.
Qin M; Chen R; Huang Z; Wang J; Xu S; Jiang R; Li J; Xian J; Wang X; Lu Y; Xu L; Chen N; Chen X; Wang P; Wang T
Food Chem Toxicol; 2019 Jan; 123():424-430. PubMed ID: 30439388
[TBL] [Abstract][Full Text] [Related]
74. The Pig-a Gene Mutation Assay in Mice and Human Cells: A Review.
Olsen AK; Dertinger SD; Krüger CT; Eide DM; Instanes C; Brunborg G; Hartwig A; Graupner A
Basic Clin Pharmacol Toxicol; 2017 Sep; 121 Suppl 3():78-92. PubMed ID: 28481423
[TBL] [Abstract][Full Text] [Related]
75. In vitro genotoxicity study of silver nanoparticles and titanium dioxide nanoparticles.
Zhu HM; Huang PC; Zhao TT; Zhou CH; Li RW; Yu CR; Chen ZY; Gu LF; Chang Y
Yi Chuan; 2020 Dec; 42(12):1192-1200. PubMed ID: 33509783
[TBL] [Abstract][Full Text] [Related]
76. Report on stage III Pig-a mutation assays using benzo[a]pyrene.
Bhalli JA; Shaddock JG; Pearce MG; Dobrovolsky VN; Cao X; Heflich RH; Vohr HW
Environ Mol Mutagen; 2011 Dec; 52(9):731-7. PubMed ID: 22052432
[TBL] [Abstract][Full Text] [Related]
77. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
78. Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies.
Knaus A; Kortüm F; Kleefstra T; Stray-Pedersen A; Đukić D; Murakami Y; Gerstner T; van Bokhoven H; Iqbal Z; Horn D; Kinoshita T; Hempel M; Krawitz PM
Am J Hum Genet; 2019 Aug; 105(2):395-402. PubMed ID: 31353022
[TBL] [Abstract][Full Text] [Related]
79. Assessment of 5-fluorouracil and 4-nitroquinoline-1-oxide in vivo genotoxicity with Pig-a mutation and micronucleus endpoints.
Zhou C; Zhang M; Huang P; Tu H; Wang Z; Dertinger SD; Torous DK; Chang Y
Environ Mol Mutagen; 2014 Dec; 55(9):735-40. PubMed ID: 25124805
[TBL] [Abstract][Full Text] [Related]
80. Assay to measure CD59 mutations in CHO A(L) cells using flow cytometry.
Ross CD; Lim CU; Fox MH
Cytometry A; 2005 Aug; 66(2):85-90. PubMed ID: 16003719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
